New Delhi: To control the dissemination of misleading claims about the treatment of COVID-19 through ayurvedic, Unani, Siddha and homeopathic drugs, the Ministry of AYUSH Wednesday instructed drug regulators to take action under provisions of the Disaster Management Act, 2005.
“Accordingly… it is hereby directed to all concerned regulatory authorities in the states and union territories to stop and prevent publicity and advertisement of AYUSH-related claims for COVID-19 treatment in print, TV and electronic media and take necessary action against the persons or agencies involved in contravening the relevant legal provisions and the aforesaid guidelines of NDMA,” it also stated.
Ads claim coronavirus cures
On 28 March, Prime Minister Narendra Modi had interacted with AYUSH practitioners and said, “AYUSH sector has a long tradition of keeping the nation healthy and its importance has increased manifold in the ongoing efforts to tackle COVID-19.”
“Struggling from increasing complaints from Advertisement Standards Council of India — ad watchdog, the ministry decided to implement this measure,” said a senior ministry official. “Social media is also flooded with fake products and false claims,” he said.
Read the full article at ThePrint